‘Celebrating Focused Ultrasound: The Future is Now,’ which will take place November 11–13, 2026, in McLean, Virginia, coincides with the Foundation’s 20th anniversary.
Sonodynamic therapy was safe and well-tolerated across multiple energy levels in nine patients with recurrent high-grade gliomas.
Focused ultrasound successfully activated the sonosensitizer in tumor tissue, with evidence of treatment-associated oxidative stress and tumor cell death in targeted regions.